x 104 Search Results


x 104  (ATCC)
93
ATCC x 104
X 104, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/x 104/product/ATCC
Average 93 stars, based on 1 article reviews
x 104 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

94
ATCC african green monkey fetal kidney cell line ma104
Statins impair rotavirus replication. (a) Caco2 cells were infected with rotavirus SA11 strain (MOI 0.7) and subsequently treated with different concentrations of atorvastatin (n = 7), lovastatin (n = 7), or simvastatin (n = 5) for 48 hours, then the intra- (left) and extracellular (right) rotavirus RNA levels were measured by qRT-PCR, and (b) rotavirus VP4 protein were measured with 50 µM atorvastatin, lovastatin, and simvastatin treatment for 48 hours respectively by western blot. In <t>MA104</t> cells, (c) treated as described in a, the intra- (left) and extracellular (right) rotavirus RNA levels with the three statins treatments respectively (n = 5), and (d) the expressions of the rotavirus VP4 protein, treated as described in b. In HSI organoids, (e) treated as described in a, the inner rotavirus RNA level with the treatments of the three statins respectively (n = 3), and (f) the expression of rotavirus VP4 protein, treated as described in b. (g) The titers of infectious rotavirus particles were measured by TCID 50 assays with 50 µM three statins treatments respectively in MA104 cells (n = 6). (h) The 96-hour time course experiments of atorvastatin (left), lovastatin (middle), and simvastatin (right) treatments respectively (n = 3) on the intracellular rotavirus RNA replication. All data presented as mean ± SEM, *p < .05, **p < .01, ***p < .001
African Green Monkey Fetal Kidney Cell Line Ma104, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/african green monkey fetal kidney cell line ma104/product/ATCC
Average 94 stars, based on 1 article reviews
african green monkey fetal kidney cell line ma104 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

94
ATCC x 104 2x 0 2 8 0 x 104 4x 2 2 streptococcus pneumoniae atcc
Statins impair rotavirus replication. (a) Caco2 cells were infected with rotavirus SA11 strain (MOI 0.7) and subsequently treated with different concentrations of atorvastatin (n = 7), lovastatin (n = 7), or simvastatin (n = 5) for 48 hours, then the intra- (left) and extracellular (right) rotavirus RNA levels were measured by qRT-PCR, and (b) rotavirus VP4 protein were measured with 50 µM atorvastatin, lovastatin, and simvastatin treatment for 48 hours respectively by western blot. In <t>MA104</t> cells, (c) treated as described in a, the intra- (left) and extracellular (right) rotavirus RNA levels with the three statins treatments respectively (n = 5), and (d) the expressions of the rotavirus VP4 protein, treated as described in b. In HSI organoids, (e) treated as described in a, the inner rotavirus RNA level with the treatments of the three statins respectively (n = 3), and (f) the expression of rotavirus VP4 protein, treated as described in b. (g) The titers of infectious rotavirus particles were measured by TCID 50 assays with 50 µM three statins treatments respectively in MA104 cells (n = 6). (h) The 96-hour time course experiments of atorvastatin (left), lovastatin (middle), and simvastatin (right) treatments respectively (n = 3) on the intracellular rotavirus RNA replication. All data presented as mean ± SEM, *p < .05, **p < .01, ***p < .001
X 104 2x 0 2 8 0 X 104 4x 2 2 Streptococcus Pneumoniae Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/x 104 2x 0 2 8 0 x 104 4x 2 2 streptococcus pneumoniae atcc/product/ATCC
Average 94 stars, based on 1 article reviews
x 104 2x 0 2 8 0 x 104 4x 2 2 streptococcus pneumoniae atcc - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

93
ATCC morganella morganii
Statins impair rotavirus replication. (a) Caco2 cells were infected with rotavirus SA11 strain (MOI 0.7) and subsequently treated with different concentrations of atorvastatin (n = 7), lovastatin (n = 7), or simvastatin (n = 5) for 48 hours, then the intra- (left) and extracellular (right) rotavirus RNA levels were measured by qRT-PCR, and (b) rotavirus VP4 protein were measured with 50 µM atorvastatin, lovastatin, and simvastatin treatment for 48 hours respectively by western blot. In <t>MA104</t> cells, (c) treated as described in a, the intra- (left) and extracellular (right) rotavirus RNA levels with the three statins treatments respectively (n = 5), and (d) the expressions of the rotavirus VP4 protein, treated as described in b. In HSI organoids, (e) treated as described in a, the inner rotavirus RNA level with the treatments of the three statins respectively (n = 3), and (f) the expression of rotavirus VP4 protein, treated as described in b. (g) The titers of infectious rotavirus particles were measured by TCID 50 assays with 50 µM three statins treatments respectively in MA104 cells (n = 6). (h) The 96-hour time course experiments of atorvastatin (left), lovastatin (middle), and simvastatin (right) treatments respectively (n = 3) on the intracellular rotavirus RNA replication. All data presented as mean ± SEM, *p < .05, **p < .01, ***p < .001
Morganella Morganii, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/morganella morganii/product/ATCC
Average 93 stars, based on 1 article reviews
morganella morganii - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

90
Jena Bioscience xtaltool ht
Statins impair rotavirus replication. (a) Caco2 cells were infected with rotavirus SA11 strain (MOI 0.7) and subsequently treated with different concentrations of atorvastatin (n = 7), lovastatin (n = 7), or simvastatin (n = 5) for 48 hours, then the intra- (left) and extracellular (right) rotavirus RNA levels were measured by qRT-PCR, and (b) rotavirus VP4 protein were measured with 50 µM atorvastatin, lovastatin, and simvastatin treatment for 48 hours respectively by western blot. In <t>MA104</t> cells, (c) treated as described in a, the intra- (left) and extracellular (right) rotavirus RNA levels with the three statins treatments respectively (n = 5), and (d) the expressions of the rotavirus VP4 protein, treated as described in b. In HSI organoids, (e) treated as described in a, the inner rotavirus RNA level with the treatments of the three statins respectively (n = 3), and (f) the expression of rotavirus VP4 protein, treated as described in b. (g) The titers of infectious rotavirus particles were measured by TCID 50 assays with 50 µM three statins treatments respectively in MA104 cells (n = 6). (h) The 96-hour time course experiments of atorvastatin (left), lovastatin (middle), and simvastatin (right) treatments respectively (n = 3) on the intracellular rotavirus RNA replication. All data presented as mean ± SEM, *p < .05, **p < .01, ***p < .001
Xtaltool Ht, supplied by Jena Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/xtaltool ht/product/Jena Bioscience
Average 90 stars, based on 1 article reviews
xtaltool ht - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Angelini Pharma clinical-molecular correlation in 104 mild x-linked muscular dystrophy patients: characterization of subclinical phenotypes
Statins impair rotavirus replication. (a) Caco2 cells were infected with rotavirus SA11 strain (MOI 0.7) and subsequently treated with different concentrations of atorvastatin (n = 7), lovastatin (n = 7), or simvastatin (n = 5) for 48 hours, then the intra- (left) and extracellular (right) rotavirus RNA levels were measured by qRT-PCR, and (b) rotavirus VP4 protein were measured with 50 µM atorvastatin, lovastatin, and simvastatin treatment for 48 hours respectively by western blot. In <t>MA104</t> cells, (c) treated as described in a, the intra- (left) and extracellular (right) rotavirus RNA levels with the three statins treatments respectively (n = 5), and (d) the expressions of the rotavirus VP4 protein, treated as described in b. In HSI organoids, (e) treated as described in a, the inner rotavirus RNA level with the treatments of the three statins respectively (n = 3), and (f) the expression of rotavirus VP4 protein, treated as described in b. (g) The titers of infectious rotavirus particles were measured by TCID 50 assays with 50 µM three statins treatments respectively in MA104 cells (n = 6). (h) The 96-hour time course experiments of atorvastatin (left), lovastatin (middle), and simvastatin (right) treatments respectively (n = 3) on the intracellular rotavirus RNA replication. All data presented as mean ± SEM, *p < .05, **p < .01, ***p < .001
Clinical Molecular Correlation In 104 Mild X Linked Muscular Dystrophy Patients: Characterization Of Subclinical Phenotypes, supplied by Angelini Pharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/clinical-molecular correlation in 104 mild x-linked muscular dystrophy patients: characterization of subclinical phenotypes/product/Angelini Pharma
Average 90 stars, based on 1 article reviews
clinical-molecular correlation in 104 mild x-linked muscular dystrophy patients: characterization of subclinical phenotypes - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Procell Inc cells from human orbital fibroblasts (1 x 104 cells/ml)
Statins impair rotavirus replication. (a) Caco2 cells were infected with rotavirus SA11 strain (MOI 0.7) and subsequently treated with different concentrations of atorvastatin (n = 7), lovastatin (n = 7), or simvastatin (n = 5) for 48 hours, then the intra- (left) and extracellular (right) rotavirus RNA levels were measured by qRT-PCR, and (b) rotavirus VP4 protein were measured with 50 µM atorvastatin, lovastatin, and simvastatin treatment for 48 hours respectively by western blot. In <t>MA104</t> cells, (c) treated as described in a, the intra- (left) and extracellular (right) rotavirus RNA levels with the three statins treatments respectively (n = 5), and (d) the expressions of the rotavirus VP4 protein, treated as described in b. In HSI organoids, (e) treated as described in a, the inner rotavirus RNA level with the treatments of the three statins respectively (n = 3), and (f) the expression of rotavirus VP4 protein, treated as described in b. (g) The titers of infectious rotavirus particles were measured by TCID 50 assays with 50 µM three statins treatments respectively in MA104 cells (n = 6). (h) The 96-hour time course experiments of atorvastatin (left), lovastatin (middle), and simvastatin (right) treatments respectively (n = 3) on the intracellular rotavirus RNA replication. All data presented as mean ± SEM, *p < .05, **p < .01, ***p < .001
Cells From Human Orbital Fibroblasts (1 X 104 Cells/Ml), supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cells from human orbital fibroblasts (1 x 104 cells/ml)/product/Procell Inc
Average 90 stars, based on 1 article reviews
cells from human orbital fibroblasts (1 x 104 cells/ml) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Merck KGaA b60.05 g mol 1
Statins impair rotavirus replication. (a) Caco2 cells were infected with rotavirus SA11 strain (MOI 0.7) and subsequently treated with different concentrations of atorvastatin (n = 7), lovastatin (n = 7), or simvastatin (n = 5) for 48 hours, then the intra- (left) and extracellular (right) rotavirus RNA levels were measured by qRT-PCR, and (b) rotavirus VP4 protein were measured with 50 µM atorvastatin, lovastatin, and simvastatin treatment for 48 hours respectively by western blot. In <t>MA104</t> cells, (c) treated as described in a, the intra- (left) and extracellular (right) rotavirus RNA levels with the three statins treatments respectively (n = 5), and (d) the expressions of the rotavirus VP4 protein, treated as described in b. In HSI organoids, (e) treated as described in a, the inner rotavirus RNA level with the treatments of the three statins respectively (n = 3), and (f) the expression of rotavirus VP4 protein, treated as described in b. (g) The titers of infectious rotavirus particles were measured by TCID 50 assays with 50 µM three statins treatments respectively in MA104 cells (n = 6). (h) The 96-hour time course experiments of atorvastatin (left), lovastatin (middle), and simvastatin (right) treatments respectively (n = 3) on the intracellular rotavirus RNA replication. All data presented as mean ± SEM, *p < .05, **p < .01, ***p < .001
B60.05 G Mol 1, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/b60.05 g mol 1/product/Merck KGaA
Average 90 stars, based on 1 article reviews
b60.05 g mol 1 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Unisantis Europe xmf-104 benchtop µ-edxrf device
Statins impair rotavirus replication. (a) Caco2 cells were infected with rotavirus SA11 strain (MOI 0.7) and subsequently treated with different concentrations of atorvastatin (n = 7), lovastatin (n = 7), or simvastatin (n = 5) for 48 hours, then the intra- (left) and extracellular (right) rotavirus RNA levels were measured by qRT-PCR, and (b) rotavirus VP4 protein were measured with 50 µM atorvastatin, lovastatin, and simvastatin treatment for 48 hours respectively by western blot. In <t>MA104</t> cells, (c) treated as described in a, the intra- (left) and extracellular (right) rotavirus RNA levels with the three statins treatments respectively (n = 5), and (d) the expressions of the rotavirus VP4 protein, treated as described in b. In HSI organoids, (e) treated as described in a, the inner rotavirus RNA level with the treatments of the three statins respectively (n = 3), and (f) the expression of rotavirus VP4 protein, treated as described in b. (g) The titers of infectious rotavirus particles were measured by TCID 50 assays with 50 µM three statins treatments respectively in MA104 cells (n = 6). (h) The 96-hour time course experiments of atorvastatin (left), lovastatin (middle), and simvastatin (right) treatments respectively (n = 3) on the intracellular rotavirus RNA replication. All data presented as mean ± SEM, *p < .05, **p < .01, ***p < .001
Xmf 104 Benchtop µ Edxrf Device, supplied by Unisantis Europe, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/xmf-104 benchtop µ-edxrf device/product/Unisantis Europe
Average 90 stars, based on 1 article reviews
xmf-104 benchtop µ-edxrf device - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Station X vehicle 104
Statins impair rotavirus replication. (a) Caco2 cells were infected with rotavirus SA11 strain (MOI 0.7) and subsequently treated with different concentrations of atorvastatin (n = 7), lovastatin (n = 7), or simvastatin (n = 5) for 48 hours, then the intra- (left) and extracellular (right) rotavirus RNA levels were measured by qRT-PCR, and (b) rotavirus VP4 protein were measured with 50 µM atorvastatin, lovastatin, and simvastatin treatment for 48 hours respectively by western blot. In <t>MA104</t> cells, (c) treated as described in a, the intra- (left) and extracellular (right) rotavirus RNA levels with the three statins treatments respectively (n = 5), and (d) the expressions of the rotavirus VP4 protein, treated as described in b. In HSI organoids, (e) treated as described in a, the inner rotavirus RNA level with the treatments of the three statins respectively (n = 3), and (f) the expression of rotavirus VP4 protein, treated as described in b. (g) The titers of infectious rotavirus particles were measured by TCID 50 assays with 50 µM three statins treatments respectively in MA104 cells (n = 6). (h) The 96-hour time course experiments of atorvastatin (left), lovastatin (middle), and simvastatin (right) treatments respectively (n = 3) on the intracellular rotavirus RNA replication. All data presented as mean ± SEM, *p < .05, **p < .01, ***p < .001
Vehicle 104, supplied by Station X, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vehicle 104/product/Station X
Average 90 stars, based on 1 article reviews
vehicle 104 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
CEM Corporation integral f(x)104, cem+pol
Statins impair rotavirus replication. (a) Caco2 cells were infected with rotavirus SA11 strain (MOI 0.7) and subsequently treated with different concentrations of atorvastatin (n = 7), lovastatin (n = 7), or simvastatin (n = 5) for 48 hours, then the intra- (left) and extracellular (right) rotavirus RNA levels were measured by qRT-PCR, and (b) rotavirus VP4 protein were measured with 50 µM atorvastatin, lovastatin, and simvastatin treatment for 48 hours respectively by western blot. In <t>MA104</t> cells, (c) treated as described in a, the intra- (left) and extracellular (right) rotavirus RNA levels with the three statins treatments respectively (n = 5), and (d) the expressions of the rotavirus VP4 protein, treated as described in b. In HSI organoids, (e) treated as described in a, the inner rotavirus RNA level with the treatments of the three statins respectively (n = 3), and (f) the expression of rotavirus VP4 protein, treated as described in b. (g) The titers of infectious rotavirus particles were measured by TCID 50 assays with 50 µM three statins treatments respectively in MA104 cells (n = 6). (h) The 96-hour time course experiments of atorvastatin (left), lovastatin (middle), and simvastatin (right) treatments respectively (n = 3) on the intracellular rotavirus RNA replication. All data presented as mean ± SEM, *p < .05, **p < .01, ***p < .001
Integral F(X)104, Cem+Pol, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/integral f(x)104, cem+pol/product/CEM Corporation
Average 90 stars, based on 1 article reviews
integral f(x)104, cem+pol - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Ingredion Inc purity gum ultra (pgu) (mw – 12.4 x 104 g/mol, degree of substitution – 0.008, lot number lki6890)
Statins impair rotavirus replication. (a) Caco2 cells were infected with rotavirus SA11 strain (MOI 0.7) and subsequently treated with different concentrations of atorvastatin (n = 7), lovastatin (n = 7), or simvastatin (n = 5) for 48 hours, then the intra- (left) and extracellular (right) rotavirus RNA levels were measured by qRT-PCR, and (b) rotavirus VP4 protein were measured with 50 µM atorvastatin, lovastatin, and simvastatin treatment for 48 hours respectively by western blot. In <t>MA104</t> cells, (c) treated as described in a, the intra- (left) and extracellular (right) rotavirus RNA levels with the three statins treatments respectively (n = 5), and (d) the expressions of the rotavirus VP4 protein, treated as described in b. In HSI organoids, (e) treated as described in a, the inner rotavirus RNA level with the treatments of the three statins respectively (n = 3), and (f) the expression of rotavirus VP4 protein, treated as described in b. (g) The titers of infectious rotavirus particles were measured by TCID 50 assays with 50 µM three statins treatments respectively in MA104 cells (n = 6). (h) The 96-hour time course experiments of atorvastatin (left), lovastatin (middle), and simvastatin (right) treatments respectively (n = 3) on the intracellular rotavirus RNA replication. All data presented as mean ± SEM, *p < .05, **p < .01, ***p < .001
Purity Gum Ultra (Pgu) (Mw – 12.4 X 104 G/Mol, Degree Of Substitution – 0.008, Lot Number Lki6890), supplied by Ingredion Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/purity gum ultra (pgu) (mw – 12.4 x 104 g/mol, degree of substitution – 0.008, lot number lki6890)/product/Ingredion Inc
Average 90 stars, based on 1 article reviews
purity gum ultra (pgu) (mw – 12.4 x 104 g/mol, degree of substitution – 0.008, lot number lki6890) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Statins impair rotavirus replication. (a) Caco2 cells were infected with rotavirus SA11 strain (MOI 0.7) and subsequently treated with different concentrations of atorvastatin (n = 7), lovastatin (n = 7), or simvastatin (n = 5) for 48 hours, then the intra- (left) and extracellular (right) rotavirus RNA levels were measured by qRT-PCR, and (b) rotavirus VP4 protein were measured with 50 µM atorvastatin, lovastatin, and simvastatin treatment for 48 hours respectively by western blot. In MA104 cells, (c) treated as described in a, the intra- (left) and extracellular (right) rotavirus RNA levels with the three statins treatments respectively (n = 5), and (d) the expressions of the rotavirus VP4 protein, treated as described in b. In HSI organoids, (e) treated as described in a, the inner rotavirus RNA level with the treatments of the three statins respectively (n = 3), and (f) the expression of rotavirus VP4 protein, treated as described in b. (g) The titers of infectious rotavirus particles were measured by TCID 50 assays with 50 µM three statins treatments respectively in MA104 cells (n = 6). (h) The 96-hour time course experiments of atorvastatin (left), lovastatin (middle), and simvastatin (right) treatments respectively (n = 3) on the intracellular rotavirus RNA replication. All data presented as mean ± SEM, *p < .05, **p < .01, ***p < .001

Journal: Gut Microbes

Article Title: Statins significantly repress rotavirus replication through downregulation of cholesterol synthesis

doi: 10.1080/19490976.2021.1955643

Figure Lengend Snippet: Statins impair rotavirus replication. (a) Caco2 cells were infected with rotavirus SA11 strain (MOI 0.7) and subsequently treated with different concentrations of atorvastatin (n = 7), lovastatin (n = 7), or simvastatin (n = 5) for 48 hours, then the intra- (left) and extracellular (right) rotavirus RNA levels were measured by qRT-PCR, and (b) rotavirus VP4 protein were measured with 50 µM atorvastatin, lovastatin, and simvastatin treatment for 48 hours respectively by western blot. In MA104 cells, (c) treated as described in a, the intra- (left) and extracellular (right) rotavirus RNA levels with the three statins treatments respectively (n = 5), and (d) the expressions of the rotavirus VP4 protein, treated as described in b. In HSI organoids, (e) treated as described in a, the inner rotavirus RNA level with the treatments of the three statins respectively (n = 3), and (f) the expression of rotavirus VP4 protein, treated as described in b. (g) The titers of infectious rotavirus particles were measured by TCID 50 assays with 50 µM three statins treatments respectively in MA104 cells (n = 6). (h) The 96-hour time course experiments of atorvastatin (left), lovastatin (middle), and simvastatin (right) treatments respectively (n = 3) on the intracellular rotavirus RNA replication. All data presented as mean ± SEM, *p < .05, **p < .01, ***p < .001

Article Snippet: Human epithelial colorectal adenocarcinoma cell line Caco2, human embryonic kidney epithelial cell line 293 T (HEK 293 T) and African green monkey fetal kidney cell line MA104 were originally purchased from ATCC (Manassas, VA, USA).

Techniques: Infection, Quantitative RT-PCR, Western Blot, Expressing

Statins inhibit the expressions of rotavirus VP6 protein . (a) Schematic depiction of the inhibitors of cholesterol biosynthesis. Following the infection of rotavirus SA11 strain (MOI 0.7) with 50 µM atorvastatin, lovastatin, or simvastatin treatment for 48 hours respectively, the expression of rotavirus VP6 protein was observed by IF staining in Caco2 cells (b), MA104 cells (c) and HSI organoids (d). VP6 protein was green, and the nuclei of the cells were visualized by DAPI (blue). The results showed that statins significantly reduced the expression of rotavirus VP6 protein

Journal: Gut Microbes

Article Title: Statins significantly repress rotavirus replication through downregulation of cholesterol synthesis

doi: 10.1080/19490976.2021.1955643

Figure Lengend Snippet: Statins inhibit the expressions of rotavirus VP6 protein . (a) Schematic depiction of the inhibitors of cholesterol biosynthesis. Following the infection of rotavirus SA11 strain (MOI 0.7) with 50 µM atorvastatin, lovastatin, or simvastatin treatment for 48 hours respectively, the expression of rotavirus VP6 protein was observed by IF staining in Caco2 cells (b), MA104 cells (c) and HSI organoids (d). VP6 protein was green, and the nuclei of the cells were visualized by DAPI (blue). The results showed that statins significantly reduced the expression of rotavirus VP6 protein

Article Snippet: Human epithelial colorectal adenocarcinoma cell line Caco2, human embryonic kidney epithelial cell line 293 T (HEK 293 T) and African green monkey fetal kidney cell line MA104 were originally purchased from ATCC (Manassas, VA, USA).

Techniques: Infection, Expressing, Staining

The inhibitors of cholesterol biosynthesis impair rotavirus replication . With rotavirus SA11 strain (MOI 0.7) infection and subsequently treated with different concentrations of 6-fluoromevalonate for 48 hours. The intra- and extracellular rotavirus RNA levels were measured by qRT-PCR (n = 6) (left) and the expressions of rotavirus VP4 protein were tested by western blot (right) in Caco2 cells (a), and in MA104 cells (b). With ZA-A treatments, the intra- and extracellular rotavirus RNA levels (n = 9) (left) and the expressions of rotavirus VP4 protein (right) in Caco2 cells (c), and in MA104 cells (d). with 1.25 µM U18666A treatment, the intra- and extracellular rotavirus RNA levels (n = 6) (left) and the expressions of rotavirus VP4 protein (right) in Caco2 cells (e), and in MA104 cells (f). In HSI organoids, the inner rotavirus RNA level with 200 µM 6-fluoromevalonate (n = 5) (g), 50 µM ZA-A (n = 5) (h) and 1.25 µM U18666A (n = 4) (i); and the expressions of rotavirus VP4 protein with 200 µM 6-fluoromevalonate or 50 µM ZA-A treatment (left) (j), with 1.25 µM U18666A treatment (right) (k). All data presented as mean ± SEM, *p < .05, **p < .01, ***p < .001

Journal: Gut Microbes

Article Title: Statins significantly repress rotavirus replication through downregulation of cholesterol synthesis

doi: 10.1080/19490976.2021.1955643

Figure Lengend Snippet: The inhibitors of cholesterol biosynthesis impair rotavirus replication . With rotavirus SA11 strain (MOI 0.7) infection and subsequently treated with different concentrations of 6-fluoromevalonate for 48 hours. The intra- and extracellular rotavirus RNA levels were measured by qRT-PCR (n = 6) (left) and the expressions of rotavirus VP4 protein were tested by western blot (right) in Caco2 cells (a), and in MA104 cells (b). With ZA-A treatments, the intra- and extracellular rotavirus RNA levels (n = 9) (left) and the expressions of rotavirus VP4 protein (right) in Caco2 cells (c), and in MA104 cells (d). with 1.25 µM U18666A treatment, the intra- and extracellular rotavirus RNA levels (n = 6) (left) and the expressions of rotavirus VP4 protein (right) in Caco2 cells (e), and in MA104 cells (f). In HSI organoids, the inner rotavirus RNA level with 200 µM 6-fluoromevalonate (n = 5) (g), 50 µM ZA-A (n = 5) (h) and 1.25 µM U18666A (n = 4) (i); and the expressions of rotavirus VP4 protein with 200 µM 6-fluoromevalonate or 50 µM ZA-A treatment (left) (j), with 1.25 µM U18666A treatment (right) (k). All data presented as mean ± SEM, *p < .05, **p < .01, ***p < .001

Article Snippet: Human epithelial colorectal adenocarcinoma cell line Caco2, human embryonic kidney epithelial cell line 293 T (HEK 293 T) and African green monkey fetal kidney cell line MA104 were originally purchased from ATCC (Manassas, VA, USA).

Techniques: Infection, Quantitative RT-PCR, Western Blot

The rotavirus titers and VP6 protein expressions of 200 µM 6-Fluoromevalonate, 50 µM ZA-A or 1.25 µM U18666A treatment . The titers of infectious rotavirus particles were measured with 200 µM 6-Fluoromevalonate (a), 50 µM ZA-A (b) or 1.25 µM U18666A (c) treatment respectively (n = 6). Following the infection of rotavirus SA11 strain (MOI 0.7) with 200 µM 6-Fluoromevalonate or 50 µM ZA-A treatment respectively for 48 hours, the expression of rotavirus VP6 protein was observed in Caco2 cells (d), the expression of rotavirus VP6 protein was observed with 1.25 µM U18666A treatment in Caco2 cells (e), and the rotavirus VP6 expressions with the above treatments in MA104 cells (f) and HSI organoids (g). VP6 protein was green, and the nuclei of the cells were visualized by DAPI (blue). The results indicated that the inhibitors reduced the expressions of rotavirus VP6 protein

Journal: Gut Microbes

Article Title: Statins significantly repress rotavirus replication through downregulation of cholesterol synthesis

doi: 10.1080/19490976.2021.1955643

Figure Lengend Snippet: The rotavirus titers and VP6 protein expressions of 200 µM 6-Fluoromevalonate, 50 µM ZA-A or 1.25 µM U18666A treatment . The titers of infectious rotavirus particles were measured with 200 µM 6-Fluoromevalonate (a), 50 µM ZA-A (b) or 1.25 µM U18666A (c) treatment respectively (n = 6). Following the infection of rotavirus SA11 strain (MOI 0.7) with 200 µM 6-Fluoromevalonate or 50 µM ZA-A treatment respectively for 48 hours, the expression of rotavirus VP6 protein was observed in Caco2 cells (d), the expression of rotavirus VP6 protein was observed with 1.25 µM U18666A treatment in Caco2 cells (e), and the rotavirus VP6 expressions with the above treatments in MA104 cells (f) and HSI organoids (g). VP6 protein was green, and the nuclei of the cells were visualized by DAPI (blue). The results indicated that the inhibitors reduced the expressions of rotavirus VP6 protein

Article Snippet: Human epithelial colorectal adenocarcinoma cell line Caco2, human embryonic kidney epithelial cell line 293 T (HEK 293 T) and African green monkey fetal kidney cell line MA104 were originally purchased from ATCC (Manassas, VA, USA).

Techniques: Infection, Expressing

Enhancement of cholesterol production provokes rotavirus replication . With rotavirus SA11 strain (MOI 0.7) infection and subsequently treated with different concentrations of R-MA for 48 hours and subsequently the intra- and extracellular rotavirus RNA levels were measured by qRT-PCR (n = 5) (left) and the expressions of rotavirus VP4 protein were tested by western blot (right) in Caco2 cells (a), and in MA104 cells (b). With different concentrations of cholesterol treatment, the intra- and extracellular rotavirus levels (n = 5) (left) and the expressions of rotavirus VP4 protein (right) in Caco2 cells (c), and in MA104 cells (d). In HSI organoids, the inner rotavirus RNA level (n = 3) (left) and the expressions of rotavirus VP4 protein (right) with R-MA treatment (e), with cholesterol treatment (f). (g) The titers of infectious rotavirus particles were measured by TCID 50 assay upon R-MA (n = 6) (left) or cholesterol (n = 6) (right) treatment respectively in MA104 cells. (h) The time-course experiment of 150 µM cholesterol treatment on the intracellular rotavirus replication. All data presented as mean ± SEM, *p < .05, **p < .01, ***p < .001

Journal: Gut Microbes

Article Title: Statins significantly repress rotavirus replication through downregulation of cholesterol synthesis

doi: 10.1080/19490976.2021.1955643

Figure Lengend Snippet: Enhancement of cholesterol production provokes rotavirus replication . With rotavirus SA11 strain (MOI 0.7) infection and subsequently treated with different concentrations of R-MA for 48 hours and subsequently the intra- and extracellular rotavirus RNA levels were measured by qRT-PCR (n = 5) (left) and the expressions of rotavirus VP4 protein were tested by western blot (right) in Caco2 cells (a), and in MA104 cells (b). With different concentrations of cholesterol treatment, the intra- and extracellular rotavirus levels (n = 5) (left) and the expressions of rotavirus VP4 protein (right) in Caco2 cells (c), and in MA104 cells (d). In HSI organoids, the inner rotavirus RNA level (n = 3) (left) and the expressions of rotavirus VP4 protein (right) with R-MA treatment (e), with cholesterol treatment (f). (g) The titers of infectious rotavirus particles were measured by TCID 50 assay upon R-MA (n = 6) (left) or cholesterol (n = 6) (right) treatment respectively in MA104 cells. (h) The time-course experiment of 150 µM cholesterol treatment on the intracellular rotavirus replication. All data presented as mean ± SEM, *p < .05, **p < .01, ***p < .001

Article Snippet: Human epithelial colorectal adenocarcinoma cell line Caco2, human embryonic kidney epithelial cell line 293 T (HEK 293 T) and African green monkey fetal kidney cell line MA104 were originally purchased from ATCC (Manassas, VA, USA).

Techniques: Infection, Quantitative RT-PCR, Western Blot

Rotavirus VP6 expressions by R-MA or cholesterol treatment . Rotavirus SA11 strain (MOI 0.7) infected Caco2 cells with 1,000 µM R-MA or 150 µM cholesterol treatment for 48 hours respectively in Caco2 cells (a), MA104 cells (b) and HSI organoids (c). Rotavirus VP6 protein was green, and the nuclei of the cells were visualized by DAPI (blue). The results showed that both of R-MA and cholesterol markedly increased the expressions of rotavirus VP6 protein

Journal: Gut Microbes

Article Title: Statins significantly repress rotavirus replication through downregulation of cholesterol synthesis

doi: 10.1080/19490976.2021.1955643

Figure Lengend Snippet: Rotavirus VP6 expressions by R-MA or cholesterol treatment . Rotavirus SA11 strain (MOI 0.7) infected Caco2 cells with 1,000 µM R-MA or 150 µM cholesterol treatment for 48 hours respectively in Caco2 cells (a), MA104 cells (b) and HSI organoids (c). Rotavirus VP6 protein was green, and the nuclei of the cells were visualized by DAPI (blue). The results showed that both of R-MA and cholesterol markedly increased the expressions of rotavirus VP6 protein

Article Snippet: Human epithelial colorectal adenocarcinoma cell line Caco2, human embryonic kidney epithelial cell line 293 T (HEK 293 T) and African green monkey fetal kidney cell line MA104 were originally purchased from ATCC (Manassas, VA, USA).

Techniques: Infection

Cholesterol provokes rotavirus replication in the absence of HMGCR activity . With rotavirus SA11 strain (MOI 0.7) infection and subsequently treated with the combination of 50 µM atorvastatin and 150 µM cholesterol for 48 hours respectively. The intra- (left) and extracellular (right) rotavirus RNA levels were measured by qRT-PCR in Caco2 cells (n = 8) (a), and in MA104 cells (n = 6) (c). The expressions of rotavirus VP4 protein were measured by western blot in Caco2 cells (b), and in MA104 cells (d). With rotavirus SA11 infection (MOI 0.7), sh10952 and sh10955 HMGCR knockdown Caco2 cells were treated with 150 µM cholesterol for 48 hours. The intra- (left) and extracellular (right) rotavirus RNA levels (n = 4) (e) and the expression of rotavirus VP4 protein (f). All data presented as mean ± SEM, *p < .05, **p < .01, ***p < .001

Journal: Gut Microbes

Article Title: Statins significantly repress rotavirus replication through downregulation of cholesterol synthesis

doi: 10.1080/19490976.2021.1955643

Figure Lengend Snippet: Cholesterol provokes rotavirus replication in the absence of HMGCR activity . With rotavirus SA11 strain (MOI 0.7) infection and subsequently treated with the combination of 50 µM atorvastatin and 150 µM cholesterol for 48 hours respectively. The intra- (left) and extracellular (right) rotavirus RNA levels were measured by qRT-PCR in Caco2 cells (n = 8) (a), and in MA104 cells (n = 6) (c). The expressions of rotavirus VP4 protein were measured by western blot in Caco2 cells (b), and in MA104 cells (d). With rotavirus SA11 infection (MOI 0.7), sh10952 and sh10955 HMGCR knockdown Caco2 cells were treated with 150 µM cholesterol for 48 hours. The intra- (left) and extracellular (right) rotavirus RNA levels (n = 4) (e) and the expression of rotavirus VP4 protein (f). All data presented as mean ± SEM, *p < .05, **p < .01, ***p < .001

Article Snippet: Human epithelial colorectal adenocarcinoma cell line Caco2, human embryonic kidney epithelial cell line 293 T (HEK 293 T) and African green monkey fetal kidney cell line MA104 were originally purchased from ATCC (Manassas, VA, USA).

Techniques: Activity Assay, Infection, Quantitative RT-PCR, Western Blot, Knockdown, Expressing

Rotavirus VP4 and VP6 proteins expressions of the combinations of atorvastatin or HMGCR knockdown and cholesterol treatment . Western blot analysis of the expressions of rotavirus VP4 protein with the combinations of 50 µM atorvastatin and 150 µM cholesterol in Caco2 cells (n = 3) (a), MA104 cells (n = 3) (b), and with the combinations of HMGCR knockdown and 150 µM cholesterol (n = 3) (c). The visual aspects of the combinations of 50 µM atorvastatin and 150 µM cholesterol in Caco2 cells (d), and MA104 cells (e), and with the combinations of HMGCR knockdown and 150 µM cholesterol treatment (f). The results showed that the combinations of atorvastatin or HMGCR knockdown and cholesterol treatment significantly increased the rotavirus replications

Journal: Gut Microbes

Article Title: Statins significantly repress rotavirus replication through downregulation of cholesterol synthesis

doi: 10.1080/19490976.2021.1955643

Figure Lengend Snippet: Rotavirus VP4 and VP6 proteins expressions of the combinations of atorvastatin or HMGCR knockdown and cholesterol treatment . Western blot analysis of the expressions of rotavirus VP4 protein with the combinations of 50 µM atorvastatin and 150 µM cholesterol in Caco2 cells (n = 3) (a), MA104 cells (n = 3) (b), and with the combinations of HMGCR knockdown and 150 µM cholesterol (n = 3) (c). The visual aspects of the combinations of 50 µM atorvastatin and 150 µM cholesterol in Caco2 cells (d), and MA104 cells (e), and with the combinations of HMGCR knockdown and 150 µM cholesterol treatment (f). The results showed that the combinations of atorvastatin or HMGCR knockdown and cholesterol treatment significantly increased the rotavirus replications

Article Snippet: Human epithelial colorectal adenocarcinoma cell line Caco2, human embryonic kidney epithelial cell line 293 T (HEK 293 T) and African green monkey fetal kidney cell line MA104 were originally purchased from ATCC (Manassas, VA, USA).

Techniques: Knockdown, Western Blot